We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

74 hedge funds and large institutions have $69.9M invested in HOOKIPA Pharma in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more capital invested

Capital invested by funds: $32.7M → $69.9M (+$37.2M)

13% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 15

3% more funds holding

Funds holding: 72 → 74 (+2)

0.67% more ownership

Funds ownership: 5.37% → 6.04% (+0.67%)

24% less call options, than puts

Call options by funds: $326K | Put options by funds: $427K

26% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 27

Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
27
Closed
15
Calls
$326K
Puts
$427K
Net Calls
-$101K
Net Calls Change
-$76K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$9.03M
2
EC
EcoR1 Capital
California
+$8.96M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.43M
4
RG
Redmile Group
California
+$4.04M
5
BBA
Baker Bros. Advisors
New York
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$1.1M
2
Renaissance Technologies
Renaissance Technologies
New York
-$915K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$776K
4
DCM
DAFNA Capital Management
California
-$747K
5
Millennium Management
Millennium Management
New York
-$657K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$17K -$16.2K -905 -56%
TRCT
52
Tower Research Capital (TRC)
New York
$13K -$25K -1,397 -72%
SWM
53
Spire Wealth Management
Virginia
$11K +$8.96K +500 New
Federated Hermes
54
Federated Hermes
Pennsylvania
$8K -$344K -19,193 -98%
AB
55
Amalgamated Bank
New York
$6K +$5.11K +285 New
AF
56
Amalgamated Financial
New York
$6K +$5.11K +285 New
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$4.66K -$4.46K -249 -55%
UBS Group
58
UBS Group
Switzerland
$4K -$14.7K -818 -83%
Legal & General Group
59
Legal & General Group
United Kingdom
$4K – – –
US Bancorp
60
US Bancorp
Minnesota
$3K – – –
Citigroup
61
Citigroup
New York
$2K -$7.44K -415 -84%
AIP
62
Ameritas Investment Partners
Nebraska
$2K – – –
EWM
63
Endurance Wealth Management
Rhode Island
$2K – – –
CAL
64
Capital Advisors Ltd
Ohio
$2K +$878 +49 +181%
JMF
65
Johnson Midwest Financial
Iowa
$2K +$1.43K +80 New
CAPTRUST Financial Advisors
66
CAPTRUST Financial Advisors
North Carolina
$1K -$1.33K -74 -63%
Rockefeller Capital Management
67
Rockefeller Capital Management
New York
$1K – – –
Osaic Holdings
68
Osaic Holdings
Arizona
$1K +$125 +7 +15%
FDCDDQ
69
Federation des caisses Desjardins du Quebec
Quebec, Canada
$752 – – –
NCM
70
Nantahala Capital Management
Connecticut
– -$1.1M -47,357 Closed
Renaissance Technologies
71
Renaissance Technologies
New York
– -$915K -39,280 Closed
Jacobs Levy Equity Management
72
Jacobs Levy Equity Management
New Jersey
– -$776K -33,289 Closed
DCM
73
DAFNA Capital Management
California
– -$747K -32,044 Closed
Millennium Management
74
Millennium Management
New York
– -$657K -28,179 Closed
Two Sigma Investments
75
Two Sigma Investments
New York
– -$611K -26,221 Closed
1 2
3
4

HOOK Hedge Fund Activity: Q1 2022 in Review

74 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2022, worth a combined $69.9M — up 114% from $32.7M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new HOOK positions and 15 closed out — a net gain of 2 holders — while 20 added to existing stakes and 27 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $9.03M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $1.1M sold.

  • 74 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2022, up from 72 in Q4 2021.
  • Funds reported $69.9M of HOOKIPA Pharma stock for Q1 2022, up 114% quarter-over-quarter.
  • 17 funds opened new HOOKIPA Pharma positions in Q1 2022 and 15 closed out, a net change of +2 holders.
  • The largest HOOKIPA Pharma buyer in Q1 2022 was Deep Track Capital, an estimated $9.03M added.
  • The largest HOOKIPA Pharma seller in Q1 2022 was Nantahala Capital Management, an estimated $1.1M sold.

Based on aggregated 13F filings for Q1 2022.